263 related articles for article (PubMed ID: 23156659)
1. Aspects of research and development contract terms in the bio/pharmaceutical sector.
Banerjee T
Adv Health Econ Health Serv Res; 2012; 23():1-33. PubMed ID: 23156659
[TBL] [Abstract][Full Text] [Related]
2. The procurement of innovation by the U.S. government.
de Rassenfosse G; Jaffe A; Raiteri E
PLoS One; 2019; 14(8):e0218927. PubMed ID: 31404070
[TBL] [Abstract][Full Text] [Related]
3. One lab, two firms, many possibilities: On R&D outsourcing in the biopharmaceutical industry.
Billette de Villemeur E; Versaevel B
J Health Econ; 2019 May; 65():260-283. PubMed ID: 31158785
[TBL] [Abstract][Full Text] [Related]
4. Evolving Outsourcing Landscape in Pharma R&D: Different Collaborative Models and Factors To Consider When Choosing a Contract Research Organization.
DeCorte BL
J Med Chem; 2020 Oct; 63(20):11362-11367. PubMed ID: 32479727
[TBL] [Abstract][Full Text] [Related]
5. The extended pharmaceutical enterprise.
Cavalla D
Drug Discov Today; 2003 Mar; 8(6):267-74. PubMed ID: 12623241
[TBL] [Abstract][Full Text] [Related]
6. Strategic drivers of contract manufacturing: Part I, The theory.
Tomlinson G; Geimer H
Med Device Technol; 2002 Dec; 13(10):14-6. PubMed ID: 12575522
[TBL] [Abstract][Full Text] [Related]
7. Do cost-sharing and entry deregulation curb pharmaceutical innovation?
Grossmann V
J Health Econ; 2013 Sep; 32(5):881-94. PubMed ID: 23896384
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with independent pharmacy owners' satisfaction with Medicare Part D contracts.
Zhang S; Doucette WR; Urmie JM; Xie Y; Brooks JM
Res Social Adm Pharm; 2010 Jun; 6(2):121-9. PubMed ID: 20511111
[TBL] [Abstract][Full Text] [Related]
9. Value of pharmaceuticals: ensuring the future of research and development.
Serajuddin HK; Serajuddin AT
J Am Pharm Assoc (2003); 2006; 46(4):511-6. PubMed ID: 16913396
[TBL] [Abstract][Full Text] [Related]
10. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
Theriaca; 2016; (43):9-61. PubMed ID: 27491172
[TBL] [Abstract][Full Text] [Related]
11. United States private-sector physicians and pharmaceutical contract research: a qualitative study.
Fisher JA; Kalbaugh CA
PLoS Med; 2012; 9(7):e1001271. PubMed ID: 22911055
[TBL] [Abstract][Full Text] [Related]
12. Joint recommendations for a total services account as a factor in simplifying contracts.
Bruns I; Schade-Brittinger C; Wissing F; Ruppert T; Trillsch M
Ger Med Sci; 2019; 17():Doc10. PubMed ID: 31728135
[TBL] [Abstract][Full Text] [Related]
13. Regulatory review time and pharmaceutical research and development.
Chorniy A; Bailey J; Civan A; Maloney M
Health Econ; 2021 Jan; 30(1):113-128. PubMed ID: 33078483
[TBL] [Abstract][Full Text] [Related]
14. Emerging trends in contract research industry in India.
Drabu S; Gupta A; Bhadauria A
Contemp Clin Trials; 2010 Sep; 31(5):419-22. PubMed ID: 20609394
[TBL] [Abstract][Full Text] [Related]
15. Measuring the efficiency of large pharmaceutical companies: an industry analysis.
Gascón F; Lozano J; Ponte B; de la Fuente D
Eur J Health Econ; 2017 Jun; 18(5):587-608. PubMed ID: 27344446
[TBL] [Abstract][Full Text] [Related]
16. Lasofoxifene: CP 336156, CP-336156.
Drugs R D; 2005; 6(1):56-60. PubMed ID: 15801869
[TBL] [Abstract][Full Text] [Related]
17. Changing R&D models in research-based pharmaceutical companies.
Schuhmacher A; Gassmann O; Hinder M
J Transl Med; 2016 Apr; 14(1):105. PubMed ID: 27118048
[TBL] [Abstract][Full Text] [Related]
18. Lessons from 60 years of pharmaceutical innovation.
Munos B
Nat Rev Drug Discov; 2009 Dec; 8(12):959-68. PubMed ID: 19949401
[TBL] [Abstract][Full Text] [Related]
19. Critical analysis of valuation and strategical orientation of merger and acquisition deals in the pharmaceutical industry.
Dierks RML; Bruyère O; Reginster JY
Expert Rev Pharmacoecon Outcomes Res; 2018 Apr; 18(2):147-160. PubMed ID: 29243501
[TBL] [Abstract][Full Text] [Related]
20. Why trash don't pass? pharmaceutical licensing and safety performance of drugs.
Banerjee T; Nayak A
Eur J Health Econ; 2017 Jan; 18(1):59-71. PubMed ID: 26781296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
